Katherine Murray - 19 May 2022 Form 3 Insider Report for CORE LABORATORIES N V

Role: Director
Signature: /s/ Mark D. Tattoli, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 19 May 2022
Net transactions value: $0
Form type: 3
Filing time: 27 May 2022, 16:57:20 UTC
Next filing: 03 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CLB	Common Shares						0	19 May 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CLB	Restricted Shares							19 May 2022	Common Shares	5,485	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Shares were granted to Ms. Murray upon her election to the Board of Supervisory Directors of Core Laboratories N.V., as part of the annual grant given to all non-executive directors on April 1, 2022, and will vest, without performance criteria, on April 1, 2023, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance.

Content

The Restricted Shares were granted to Ms. Murray upon her election to the Board of Supervisory Directors of Core Laboratories N.V., as part of the annual grant given to all non-executive directors on April 1, 2022, and will vest, without performance criteria, on April 1, 2023, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance.